Russell Investments Group
CLSD

Russell Investments Group’s Clearside Biomedical CLSD Stock Holding History

Russell Investments Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10
Closed -$138 – 3811
2024
Q4 		$138 Hold
10
– – ﹤0.01% 3668
2024
Q3 		$184 Sell
10
-6
-38% -$102 ﹤0.01% 3644
2024
Q2 		$316 Buy
+16
New +$309 ﹤0.01% 3529
2018
Q4 		– Sell
-10,595
Closed -$977K – 2932
2018
Q3 		$977K Buy
10,595
+5,369
+103% +$638K ﹤0.01% 2117
2018
Q2 		$838K Sell
5,226
-2,910
-36% -$491K ﹤0.01% 2204
2018
Q1 		$1.31M Buy
8,136
+565
+7% +$68.8K ﹤0.01% 2080
2017
Q4 		$794K Buy
+7,571
New +$813K ﹤0.01% 2254

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group's CLSD Position: Q1 2025 in Review

Russell Investments Group sold out of Clearside Biomedical (CLSD) in Q1 2025, closing a stake of 10 shares — an estimated $138 sold.

Russell Investments Group first reported a position in CLSD in Q4 2017 and held it in 7 quarters. The position peaked at $1.31M in Q1 2018. 43 funds tracked by Wall St. Rank hold CLSD as of Q1 2025.

  • Russell Investments Group reported no remaining Clearside Biomedical position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 10 Clearside Biomedical shares in Q1 2025, an estimated $138.
  • Russell Investments Group first reported a position in Clearside Biomedical in Q4 2017 and held it in 7 quarters.
  • Russell Investments Group's Clearside Biomedical position peaked at $1.31M in Q1 2018.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.